Novo renews Madrid Excelente seal for the third consecutive year

The pharmaceutical company is recognized for its innovation, social commitment, people management, and cybersecurity, according to the Madrid Excelente evaluation.

Generic image.
AI

Generic image.

The Community of Madrid, through Madrid Excelente, has renewed its quality seal for the pharmaceutical company Novo for the third consecutive year, acknowledging its commitment to innovation, sustainability, and social responsibility.

Madrid, November 3, 2026. Madrid Excelente, the quality certification of the Community of Madrid, has renewed its trust for the third consecutive year in Novo as a global healthcare company committed to the highest standards of quality, innovation, sustainability, and social responsibility. This recognition follows an exhaustive analysis by independent experts who have evaluated the company's commitment across the four pillars of the Madrid Excelente model: purpose, people, planet, and progress.
The audit examined key areas such as strategy, ethics, results, environmental impact, social commitment, people management, relationships with clients and suppliers, innovation capacity, and corporate transformation. Elena Matilla, Director General of Madrid Excelente, highlighted that "Novo is an example of how research and collaboration can contribute to improving people's health and quality of life. Companies like this are fundamental to continuing to drive the pharmaceutical sector and reinforce the role of Madrid's healthcare system as a benchmark for innovation".
Novo's purpose of fostering quality health that endures over time through innovation and knowledge generation has been a key theme for obtaining the seal. In 2025, the company invested 10.3 million euros in R&D&i in Spain and actively participated in the Cluster of Innovation in Biomedical and Biotechnology Technologies of the Community of Madrid.
Paula Barriga, Director General of Novo Spain, stated: "Through our activities, we are honoring our purpose of working for quality health that endures over time, both inside and outside the organization. We rely on innovation, scientific collaboration, the promotion of healthy lifestyle habits for integral well-being, social awareness of chronic diseases, and technological security."
The Chair of Obesity, along with the Royal Academy of Pharmacy and the Community of Madrid, has been another highlighted pillar, bringing together professionals to better understand the disease. Furthermore, Novo has strengthened its commitment to technological security, validated by the Madrid Excelente Lugar Ciberseguro (Cybersecure Place) designation.
Based on information from the official source: Madrid Excelente (19/11/2026)